{"DataElement":{"publicId":"2195256","version":"1","preferredName":"Common Toxicity Criteria Adverse Event Soft Tissue Necrosis Grade","preferredDefinition":"in CTC category Musculoskeletal/Soft Tissue, assessment of the severity of an adverse event for the supraordinate term soft tissue necrosis - select using a graded scale.","longName":"CTC_AE_SFTIS_NECR_GD","context":"CTEP","contextVersion":"2.31","DataElementConcept":{"publicId":"2195253","version":"2","preferredName":"Common Toxicity Criteria Adverse Event Soft Tissue Necrosis","preferredDefinition":"information related to the CTC adverse event of soft tissue necrosis","longName":"CTC_AE_SOFTISS_NECR","context":"CTEP","contextVersion":"2.31","ObjectClass":{"publicId":"2480706","version":"1","preferredName":"Common Terminology Criteria for Adverse Events","preferredDefinition":"A standard terminology developed to report adverse events occurring in cancer clinical trials.  Common terminology criteria for adverse events (CTCAE) are used in study adverse event summaries and Investigational New Drug reports to the Food and Drug Administration.  The CTCAE contain a grading scale for each adverse event term representing the severity of the event.","longName":"C49704","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Common Terminology Criteria for Adverse Events","conceptCode":"C49704","definition":"A standard terminology developed to report adverse events occurring in cancer clinical trials.  Common terminology criteria for adverse events (CTCAE) are used in study adverse event summaries and Investigational New Drug reports to the Food and Drug Administration.  The CTCAE contain a grading scale for each adverse event term representing the severity of the event.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"133A63CA-49B0-49FD-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-05-07","endDate":null,"createdBy":"REEVESD","dateCreated":"2006-05-07","modifiedBy":"ONEDATA","dateModified":"2006-05-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"2660815","version":"1","preferredName":"Soft Tissue Necrosis","preferredDefinition":"Refers to muscle, fat, fibrous tissue, blood vessels, or other supporting tissue of the body.:The pathologic localized death of living cells, as from infection or interruption of the blood supply, generally associated with severe cellular trauma caused by progressive degradation by enzymes. Characterized by mitochondrial swelling, nuclear flocculation, and uncontrolled cell lysis, it is unprogrammed death of living tissue and cells.","longName":"C12471:C16897","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Soft Tissue","conceptCode":"C12471","definition":"A general term comprising tissue that is not hardened or calcified; including muscle, fat, blood vessels, nerves, tendons, ligaments and fascia.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Necrotic Process","conceptCode":"C16897","definition":"A cell death process that is morphologically characterized by a gain in cell volume (oncosis), swelling of organelles, plasma membrane rupture and subsequent loss of intracellular contents.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"33E73C82-D49D-5882-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-06-27","endDate":null,"createdBy":"SBREXT","dateCreated":"2007-06-27","modifiedBy":"ONEDATA","dateModified":"2007-06-27","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008517","version":"1","preferredName":"Adverse Events","preferredDefinition":"any unfavorable symptoms, signs, or disease temporally associated with the use of a medical\r\ntreatment or procedure that may or may not be considered related to the medical\r\ntreatment or procedure.","longName":"AE","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"AB51E03C-635E-5672-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-09-23","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-09-23","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":"Definition copied from CTC Manual.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B2045A13-8799-ADB5-E040-BB89AD4374D9","latestVersionIndicator":"Yes","beginDate":"2005-01-07","endDate":null,"createdBy":"ALAIS","dateCreated":"2011-11-18","modifiedBy":"SBR","dateModified":"2016-06-06","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"2195255","version":"1","preferredName":"Common Toxicity Criteria Adverse Event Soft Tissue Necrosis Grade","preferredDefinition":"in CTC category Musculoskeletal/Soft Tissue, assessment of the severity of an adverse event for the supraordinate term soft tissue necrosis - select using a graded scale.","longName":"CTC_AE_SFTIS_NECR_GD","context":"CTEP","contextVersion":"2.31","type":"Enumerated","dataType":"CHARACTER","minLength":"1","maxLength":"1","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"0","valueDescription":"None at all","ValueMeaning":{"publicId":"2574138","version":"1","preferredName":"None at all","longName":"2574138","preferredDefinition":"No person or thing, nobody, not any.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"None","conceptCode":"C41132","definition":"No person or thing, nobody, not any.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-EEA7-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2003-11-14","endDate":null,"createdBy":"SBREXT","dateCreated":"2003-11-14","modifiedBy":"CLOHNES","dateModified":"2022-08-12","changeDescription":null,"administrativeNotes":"8/12/22 added alt VM for Alliance cjl;","unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"ED18660F-36E6-4FAB-E034-0003BA3F9857","beginDate":"2004-08-17","endDate":null,"createdBy":"SHIDED","dateCreated":"2005-01-07","modifiedBy":"SBR","dateModified":"2005-03-29","deletedIndicator":"No"},{"value":"2","valueDescription":"Local wound care; medical intervention indicated","ValueMeaning":{"publicId":"2571631","version":"1","preferredName":"Local wound care; medical intervention indicated","longName":"2571631","preferredDefinition":"Local wound care; medical intervention indicated","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-E4DC-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2004-08-17","endDate":null,"createdBy":"SHIDED","dateCreated":"2004-08-17","modifiedBy":"SHIDED","dateModified":"2004-08-17","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"ED18660F-36E8-4FAB-E034-0003BA3F9857","beginDate":"2004-08-17","endDate":null,"createdBy":"SHIDED","dateCreated":"2005-01-07","modifiedBy":"SBR","dateModified":"2005-03-29","deletedIndicator":"No"},{"value":"3","valueDescription":"Operative debridement or other invasive intervention indicated (e.g., hyperbaric oxygen)","ValueMeaning":{"publicId":"2571632","version":"1","preferredName":"Operative debridement or other invasive intervention indicated (e.g., hyperbaric oxygen)","longName":"2571632","preferredDefinition":"Operative debridement or other invasive intervention indicated (e.g., hyperbaric oxygen)","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-E4DD-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2004-08-17","endDate":null,"createdBy":"SHIDED","dateCreated":"2004-08-17","modifiedBy":"SHIDED","dateModified":"2004-08-17","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"ED18660F-36EA-4FAB-E034-0003BA3F9857","beginDate":"2004-08-17","endDate":null,"createdBy":"SHIDED","dateCreated":"2005-01-07","modifiedBy":"SBR","dateModified":"2005-03-29","deletedIndicator":"No"},{"value":"4","valueDescription":"Life-threatening consequences; major invasive intervention indicated (e.g., tissue reconstruction, flap, or grafting)","ValueMeaning":{"publicId":"2571633","version":"1","preferredName":"Life-threatening consequences; major invasive intervention indicated (e.g., tissue reconstruction, flap, or grafting)","longName":"2571633","preferredDefinition":"Life-threatening consequences; major invasive intervention indicated (e.g., tissue reconstruction, flap, or grafting)","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-E4DE-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2004-08-17","endDate":null,"createdBy":"SHIDED","dateCreated":"2004-08-17","modifiedBy":"SHIDED","dateModified":"2004-08-17","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"ED18660F-36EC-4FAB-E034-0003BA3F9857","beginDate":"2004-08-17","endDate":null,"createdBy":"SHIDED","dateCreated":"2005-01-07","modifiedBy":"SBR","dateModified":"2005-03-29","deletedIndicator":"No"},{"value":"5","valueDescription":"Death","ValueMeaning":{"publicId":"2567604","version":"1","preferredName":"Death","longName":"2567604","preferredDefinition":"The cessation of life.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Dead","conceptCode":"C28554","definition":"The cessation of life.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-D521-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2003-12-31","endDate":null,"createdBy":"SBREXT","dateCreated":"2003-12-31","modifiedBy":"COOPERM","dateModified":"2015-11-24","changeDescription":"Added the NCIt concept definition as the System Generated definition per request by NMDP. mc 11/24/15","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"ED18660F-36EE-4FAB-E034-0003BA3F9857","beginDate":"2002-10-11","endDate":null,"createdBy":"SHIDED","dateCreated":"2005-01-07","modifiedBy":"SBR","dateModified":"2005-03-29","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008517","version":"1","preferredName":"Adverse Events","preferredDefinition":"any unfavorable symptoms, signs, or disease temporally associated with the use of a medical\r\ntreatment or procedure that may or may not be considered related to the medical\r\ntreatment or procedure.","longName":"AE","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"AB51E03C-635E-5672-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-09-23","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-09-23","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":"Definition copied from CTC Manual.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"2184299","version":"1","preferredName":"Grade","preferredDefinition":"Describes how closely a cancer resembles normal tissue of its same type, and the cancer's probable rate of growth","longName":"Grade","context":"CTEP","contextVersion":"2.31","Concepts":[{"longName":"Histologic Grade","conceptCode":"C18000","definition":"The degree of abnormality of cancer cells, a measure of differentiation, the extent to which cancer cells are similar in appearance and function to healthy cells of the same tissue type. The degree of differentiation often relates to the clinical behavior of the particular tumor. Based on the microscopic findings, tumor grade is commonly described by one of four degrees of severity. Histopathologic grade of a tumor may be used to plan treatment and estimate the future course, outcome, and overall prognosis of disease. Certain types of cancers, such as soft tissue sarcoma, primary brain tumors, lymphomas, and breast have special grading systems.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"DB6C8AC6-1C87-3E75-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2004-05-27","endDate":null,"createdBy":"SBREXT","dateCreated":"2004-05-27","modifiedBy":"SBR","dateModified":"2005-03-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"ED1871E0-6B2B-5E8A-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-01-07","endDate":null,"createdBy":"SHIDED","dateCreated":"2005-01-07","modifiedBy":"REEVESD","dateModified":"2014-01-12","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"2008589","version":"2","longName":"Type of Category","context":"CTEP","ClassificationSchemeItems":[{"publicId":"2812032","version":"1","longName":"Common Terminology Criteria for Adverse Events v3.0","context":"CTEP"}]},{"publicId":"2604617","version":"1","longName":"Submission and Reporting","context":"CTEP","ClassificationSchemeItems":[{"publicId":"10000132","version":"1","longName":"Common Terminology Criteria for Adverse Events v3.0","context":"CTEP"}]}],"AlternateNames":[],"ReferenceDocuments":[{"name":"CTC Adverse Event Soft tissue","type":"Preferred Question Text","description":"CTC Adverse Event Soft tissue necrosis - Select Grade","url":null,"context":"CTEP"},{"name":"CRF Text","type":"Alternate Question Text","description":"Soft tissue necrosis - Select Grade","url":null,"context":"CTEP"},{"name":"Source","type":"DATA_ELEMENT_SOURCE","description":"Data element and all values comply with Common Terminology Criteria for Adverse Events v3.0 (CTCAE)","url":"http://ctep.cancer.gov/reporting/ctc.html","context":"CTEP"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"ED18660F-36D2-4FAB-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-01-07","endDate":null,"createdBy":"SHIDED","dateCreated":"2005-01-07","modifiedBy":"ALAIS","dateModified":"2011-11-18","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}